WHO ICTRP trial

Clinical study comparing the performance of two substances, albumin and plasma…

EUCTR2014-000177-39-IT · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2014-000177-39-IT
Public title Clinical study comparing the performance of two substances, albumin and plasma, during cardiac operations of pediatric patients.
Scientific title Albumin vs. Plasma for PEdiAtric pRiming (APPEAR) trial - APPEAR
Primary sponsor IRCCS Policlinico San Donato
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes
Countries Italy
Conditions Congenital cardiac diseases needing surgical correction requiring intervention with extracorporeal circulation;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
Interventions Trade Name: Albumin 5% Product Name: Albumin Pharmaceutical Form: Concentrate for solution for infusion
Registration date Mar 21, 2014
Secondary IDs Linea7-2013/06-APPEAR
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations